Key facts
- This page summarizes Commodore Capital LP's Form 4 filing for Vera Therapeutics, Inc. (VERA).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 12 Jan 2024, 21:55.
Commodore Capital LP - 10 Jan 2024 Form 4 Insider Report for Vera Therapeutics, Inc. (VERA)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- VERA
- Reported as of
- 10 Jan 2024
- Net transaction value
- -$18,900,000
- SEC form
- 4
- Accepted by SEC
- 12 Jan 2024, 21:55:09 UTC
- Prior SEC filing
- 06 Oct 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Michael Kramarz, Managing Partner
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Commodore Capital LP filed Form 4 for Vera Therapeutics, Inc. (VERA) on 12 Jan 2024.
Change
- Previous filing in this sequence was filed on 06 Oct 2023.
- Current net transaction value: -$18,900,000.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
VERA
transaction
Class A Common Stock
Sale
- Transaction value
- $18,900,000
- Shares
- -1,050,000
- Change %
- -19%
- Price
- $18.00
- Shares after
- 4,400,000
- Date
- 10 Jan 2024
- Ownership
- By Commodore Capital Master LP
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Commodore Capital LP is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 1 footnote
Footnote F1
The shares are held directly by Commodore Capital Master LP ("Commodore Master"). Commodore Capital LP ("Commodore Capital") is the investment manager to Commodore Master. Michael Kramarz and Robert Egen Atkinson are the managing partners of Commodore Capital and exercise investment and dispositive power over the securities held by Commodore Master. Each of Commodore Capital, Dr. Kramarz and Dr. Atkinson disclaim beneficial ownership of such securities, except to the extent of their pecuniary interest therein. This report shall not be deemed an admission that Commodore Capital, Commodore Master, Dr. Kramarz and Dr. Atkinson or any other person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.